Release of dipeptidyl peptidase IV, α-amylase and α-glucosidase inhibitory peptides from quinoa (Chenopodium quinoa Willd.) during in vitro simulated gastrointestinal digestion

Journal of Functional Foods

Volumn 35, Issue , 2017, Pages 531-539

  Vilcacundo, Rubén ^a,b   Martínez Villaluenga, Cristina ^c   Hernández Ledesma, Blanca ^a  

^a INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

^b UNIVERSIDAD TÉCNICA DE AMBATO   (Ecuador)

^c INSTITUTE OF FOOD SCIENCE   (Spain)

Author keywords

Anti diabetic activity; Bioactive peptides; Quinoa; Simulated gastrointestinal digestion

Indexed keywords

EID: 85020943757     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2017.06.024     Document Type: Article

References (60)

1. Abugoch, L.E., Romero, N., Tapia, C., Silva, J., Rivera, M., Study of some physicochemical and functional properties of quinoa (Chenopodium quinoa Willd) protein isolates. Journal of Agricultural and Food Chemistry 56 (2008), 4745–4750.
2. Aluko, R.E., Monu, E., Functional and bioactive properties of quinoa seed protein hydrolysates. Food Chemical Toxicology 68 (2003), 1254–1258.
3. Babij, K., Dabrowska, A., Szołtysik, M., Pokora, M., Zambrowicz, A., Chrzanowska, J., The evaluation of dipeptidyl peptidase (DPP)-IV, α-glucosidase and angiotensin converting enzyme (ACE) inhibitory activities of whey proteins hydrolyzed with serine protease isolated from Asian pumpkin (Cucurbita ficifolia). International Journal of Peptide Research and Therapeutics 20 (2014), 483–491.
4. Bharatham, K., Bharatham, N., Park, K.H., Lee, K.W., Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of α-glucosidase inhibitors. Journal of Molecular Graphics and Modelling 26 (2008), 1202–1212.
5. Brinegar, C., Goundan, S., Isolation and characterization of chenopodin, the 11S seed storage protein of quinoa (Chenopodium quinoa). Journal of Agricultural and Food Chemistry 41 (1993), 182–185.
6. Brinegar, C., Sine, B., Nwokocha, L., High-cysteine 2S seed storage proteins from quinoa (Chenopodium quinoa). Journal of Agricultural and Food Chemistry 44 (1996), 1621–1623.
7. De Fronzo, R., Pharmacologic therapy for type 2 diabetes mellitus. Annals of International Medicine 131 (1999), 281–303.
8. Deacon, C.F., Hughes, T.E., Holst, J.J., Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes 47 (1998), 764–769.
9. Deacon, C.F., Nauck, M.A., Meier, J., Hücking, K., Holst, J.J., Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetes subjects as revealed using a new assay for the intact peptide. Journal of Clinical Endocrinology & Metabolism 85 (2000), 3575–3581.
10. El Abed, H., Chakroun, M., Fendri, I., Makni, M., Bouaziz, M., Drira, N.,.. Khemakhem, B., Extraction optimization and in vitro and in vivo anti-postprandial hyperglycemia effects of inhibitor from Phoenix dactylifera L. parthenocarpic fruit. Biomedicine & Pharmacotherapy 88 (2017), 835–843.
11. Gonçalves, R., Mateus, N., de Freitas, V., Inhibition of α-amylase activity by condensed tannins. Food Chemistry 125 (2011), 665–672.
12. Hernández-Ledesma, B., Miralles, B., Amigo, L., Ramos, M., Recio, I., Identification of antioxidant and ACE-inhibitory peptides in fermented milk. Journal of the Science of Food and Agriculture 85 (2005), 1041–1048.
13. Holst, J.J., Deacon, C.F., Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. Current Opinion in Pharmacology 4 (2004), 589–596.
14. Huang, S.L., Jao, C.L., Ho, K.P., Hsu, K.C., Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates. Peptides 35 (2012), 114–121.
15. Hunziker, D., Henning, M., Peters, J.-U., Inhibitors of dipeptidyl peptidase IV- recent advances and structural views. Current Topics in Medicinal Chemistry 5 (2005), 1623–1637.
16. Jao, C.-L., Hung, C.-C., Tung, Y.-S., Lin, P.-Y., Chen, M.-C., Hsu, K.-C., The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes. BioMedicine 5 (2015), 9–15.
17. Johnson, M.H., Lucius, A., Meyer, T., de Mejia, E.G., Cultivar evaluation and effect of fermentation on antioxidant capacity and in vitro inhibition of α-amylase and α-glucosidase by highbush blueberry (Vaccinium corombosum). Journal of Agricultural and Food Chemistry 59 (2011), 8923–8930.
18. Lacroix, I.M.E., Li-Chan, E.C.Y., Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. International Dairy Journal 25 (2012), 97–102.
19. Lacroix, I.M.E., Li-Chan, E.C.Y., Inhibition of dipeptidyl peptidase (DPP)-IV and α-glucosidase activities by pepsin-treated whey proteins. Journal of Agricultural and Food Chemistry 61 (2013), 7500–7506.
20. Majumdar, S.K., Inzucchi, S.E., Investigational antihyperglycemic agents: The future of type 2 diabetes therapy?. Endocrine 44 (2013), 47–58.
21. Matsui, T., Yoshimoto, C., Osajima, K., Oki, T., Osajima, Y., In vitro survey of α-glucosidase inhibitory food components. Bioscience, Biotechnology, and Biochemistry 60 (1996), 2019–2022.
22. McIntosh, C.H.S., Demuth, H.-U., Pospisilik, J.A., Pederson, R., Dipeptidyl peptidase IV inhibitors: How do they work as new antidiabetic agents?. Regulatory Peptides 128 (2005), 159–165.
23. Mentlein, R., Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs. Expert Opinion on Investigational Drugs 14 (2005), 57–64.
24. Minekus, M., Alminger, M., Alvito, P., Balance, S., Bohn, T., Bourlieu, C.,.. Brodkorb, A., A standardised static in vitro digestion method suitable for food – An international consensus. Food & Function 5 (2014), 1113–1124.
25. Mitani, H., Takimoto, M., Hughes, T.E., Kimura, M., Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: Study using a Fischer 344 rat substrain deficient in its enzyme activity. Japanese Journal of Pharmacology 88 (2002), 442–450.
26. Mochida, T., Hira, T., Hara, H., The corn protein, zein hydrolysate, administered into ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology 151 (2010), 3095–3104.
27. Mojica, L., de Mejia, E.G., Optimization of enzymatic production of anti-diabetic peptides from black bean (Phaseolus vulgaris L.) proteins, their characterization and biological potential. Food & Function 7 (2016), 713–727.
28. Nauck, M.A., Kleine, N., Ørskov, C., Holst, J.J., Willms, B., Creutzfeldt, C., Normalization of fasting hyperglycemia by exogenous-1 (7–36 amide) in type 2 GLP diabetic patients. Diabetologia 36 (1993), 741–744.
29. Nauck, M.A., Wollschlager, D., Werner, J., Holst, J.J., Ørskov, C., Creutzfeldt, W., Willms, B., Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7–36 amide]) in patients with NIDDM. Diabetologia 39 (1996), 1546–1553.
30. Ngoh, Y.-Y., Gan, C.-Y., Enzyme-assisted extraction and identification of antioxidative and α-amylase inhibitory peptides from Pinto beans (Phaseolus vulgaris cv. Pinto). Food Chemistry 190 (2016), 331–337.
31. Nongonierma, A.B., FitzGerald, R.J., An in silico model to predict the potential of dietary proteins as sources of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides. Food Chemistry 165 (2014), 489–498.
32. Nongonierma, A.B., Fitzgerald, R.J., Investigation of the potential of hemp, pea, rice and soy protein hydrolysates as a source of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides. Food Digestion 6 (2015), 19–29.
33. Nongonierma, A.B., Le Maux, S., Dubrulle, C., Barre, C., FitzGerald, R.J., Quinoa (Chenopodium quinoa Willd.) protein hydrolysates with in vitro dipeptidyl peptidase IV (DPP-IV) inhibitory and antioxidant properties. Journal of Cereal Science 65 (2015), 112–118.
34. Oki, T., Matsui, T., Osajima, Y., Inhibitory effect of α-glucosidase inhibitors varies according to its origin. Journal of Agricultural and Food Chemistry 47 (1999), 550–553.
35. Oseguera-Toledo, M.E., Gonzalez de Mejia, E., Amaya-Llano, S.L., Hard-to-cook bean (Phaseolus vulgaris L.) proteins hydrolyzed by alcalase and bromelain produced bioactive peptide fractions that inhibit targets of type-2 diabetes and oxidative stress. Food Research International 76 (2015), 839–851.
36. Patil, P., Mandal, S., Kumar Tomar, S., Anand, S., Food protein-derived bioactive peptides in management of type 2 diabetes. European Journal of Nutrition 54 (2015), 863–880.
37. Pieter, B. J.-W. (2006). Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use. WO 2006/068480 200.
38. Power, O., Hallihan, A., Jakeman, P., Human insulinotropic response to oral ingestion of native and hydrolysed whey protein. Amino Acids 37 (2009), 333–339.
39. Power, O., Nongonierma, A.B., Jakeman, P., FitzGerald, R.J., Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes. Proceedings of the Nutrition Society 73 (2014), 34–46.
40. Ren, Y., Liang, K., Jin, Y., Zhang, M., Chen, Y., Wu, H., Lai, F., Identification and characterization of two novel α-glucosidase inhibitory oligopeptides from hemp (Cannabis sativa L.) seed protein. Journal of Functional Foods 26 (2016), 439–450.
41. Repo-Carrasco, R., Espinoza, C., Jacobsen, S.E., Nutritional value and use of the Andean crops quinoa (Chenopodium quinoa) and kaniwa (Chenopodium pallidicaule). Food Reviews International 19 (2003), 179–189.
42. Richardson, M., Seed storage proteins: The enzyme inhibitors. Methods in Plant Biochemistry 5 (1991), 259–305.
43. Robertson, R.P., Antagonist: Diabetes and insulin resistance-philosophy, science, and the multiplier hypothesis. Journal of Laboratory and Clinical Medicine 125 (1995), 560–564.
44. Roskar, I., Molek, P., Vodnik, M., Stempelj, M., Strukelj, B., Lunder, M., Peptide modulators of alpha-glucosidase. Journal of Diabetes Investigation 6 (2015), 625–631.
45. Satoh, T., Igarashi, M., Yamada, S., Takahashi, N., Watanabe, K., Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity. Journal of Ethnopharmacology 161 (2015), 147–155.
46. Silveira, S.T., Martínez-Maqueda, D., Recio, I., Hernández-Ledesma, B., Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chemistry 141 (2013), 1072–1077.
47. Siow, H.-L., Gan, C.-Y., Extraction, identification, and structure-activity relationships of antioxidative and α-amylase inhibitory peptides from cumin seeds (Cuminum cyminum). Journal of Functional Foods 22 (2016), 1–12.
48. Siow, H.-L., Gan, C.-Y., Optimization study in extracting anti-oxidative and α-amylase inhibitor peptides from cumin seeds (Cuminum cyminum). Journal of Food Biochemistry, 41, 2017, e12280.
49. Siow, H.-L., Lim, T.S., Gan, C.-Y., Development of a workflow for screening and identification of α-amylase inhibitory peptides from food source using an integrated Bioinformatics-phage display approach: Case study - Cumin seed. Food Chemistry 214 (2017), 67–76.
50. Takao, T., Watanabe, N., Yuhara, K., Itoh, S., Suda, S., Tsuruoka, Y.,.. Konish, Y., Hypocholesterolemic effect of protein isolated from quinoa (Chenopodium quinoa Willd.) seeds. Food Science & Technology Research 11 (2005), 161–167.
51. Toapanta, A., Carpio, C., Vilcacundo, R., Carrillo, W., Analysis of protein isolate from quinoa (Chenopodium quinoa Willd.). Asian Journal of Pharmaceutical and Clinica Research 9 (2016), 332–334.
52. Tulipano, G., Faggi, L., Nardone, A., Cocchi, D., Caroli, A.M., Characterization of the potential of β-lactoglobulin and α-lactalbumin as sources of bioactive peptides affecting incretin function: in silico and in vitro comparative studies. International Dairy Journal 48 (2015), 66–72.
53. Uenishi, H., Kabuki, T., Seto, Y., Serizawa, A., Nakajima, H., Isolation and identification of casein-derived dipeptidyl-peptidase-4 (DPP-4)-inhibitory peptide LPQNIPPL from gouda-type cheese and its effect on plasma glucose in rats. International Dairy Journal 22 (2012), 24–30.
54. Uraipong, C., Zhao, J., Rice bran protein hydrolysates exhibit strong in vitro α-amylase, β-glucosidase and ACE-inhibition activities. Journal of the Science of Food and Agriculture 96 (2016), 1101–1110.
55. Velarde-Salcedo, A.J., Barrera-Pacheco, A., Lara-González, S., Montero-Morán, G.M., Díaz-Gois, A., Gonzalez de Mejia, E., Barba de la Rosa, A.P., In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins. Food Chemistry 136 (2013), 758–764.
56. Vilcacundo, R., Hernández-Ledesma, B., Nutritional and biological value of quinoa (Chenopodium quinoa Willd.). Current Opinion in Food Science 14 (2017), 1–6.
57. Wang, F., Yu, G., Zhang, Y., Zhang, B., Fan, J., Dipeptidyl peptidase IV inhibitory peptides derived from oat (Avena sativa L.), buckwheat (Fagopyrum esculentum), and highland barley (Hordeum vulgare trifurcatum (L.) Trofim) proteins. Journal of Agricultural and Food Chemistry 63 (2015), 9543–9549.
58. World Health Organization (2016). Diabetes fact sheet. accessed May 25, 2016. http://www.who.int/mediacentre/factsheets/fs312/en/.
59. You, Q., Chen, F., Wang, X., Jiang, Y., Lin, S., Anti-diabetic activities of phenolic compounds in muscadine against alpha-glucosidase and pancreatic lipase. Food Science and Technology 46 (2012), 164–168.
60. Yu, Z., Yin, Y., Zhao, W., Yu, Y., Liu, B., Liu, J., Chen, F., Novel peptides derived from egg white protein inhibiting alpha-glucosidase. Food Chemistry 129 (2011), 1376–1382.